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  ABBREVIATIONS 
 
Abbreviation Meaning 
ANC Antenatal Care 
AST Aspartate aminotransferase 
CHT Chronic hypertension 
CRD Chronic renal disease 
CT scan Computed tomography 
C/S Caesarean section 
CVP Central venous pressure 
DIC Disseminated intravascular coagulation 
EEG Electroencephalogram 
GFR Glomerular filtration rate 
IUGR Intrauterine growth restriction 
MRI Magnetic resonance imaging 
NICU Neonatal Intensive Care Unit 
NVD Normal vaginal delivery 
PE Pre-eclampsia 
PG Prostaglandin 
PIH Pregnancy induced hypertension 
PPH Postpartum haemorrhage 
 
 





This was a comparative prospective case-control 
study carried out in two main maternity units in the period 
from 15th of September 2004 to 15th of March 2005.  
Informations were collected from patients presented 
to the labour ward, and those patients were followed till 
delivery in Omdurman maternity Hospital and Ribat 
National Hospital using a questionnaire.  
A sum of 80 cases and 80 controls were collected to 
study the pregnancy induced hypertension (PIH) effect on 
their placental weight.  
Most of the study group were in the age group 
between 20 to 29 years, which is about 52% of the cases 
and 67% of the control group, and most of the study group 
were from urban areas. Thirty two percent of the cases and 
37% of control group were primigravidae. Twenty-two 
percent of the babies in the case group had resuscitation 
and admitted to Neonatal Intensive Care Unit (NICU). Fifteen 
percent of the babies in the cases their weight is <1.5kg.  
Correlation was done between placental weight and 
 
   
  
  foetal weight and was found to be significant (Fisher exact = 
0.014), also there was significant correlation between foetal 
outcome and gestational age (Fisher's exact = 0.001) and 
significant correlation between foetal outcome and mode of 
delivery (Fisher's exact = 0.029). Correlation between foetal 
weight and gestational age was found to be marginally 
significant (Fisher's exact = 0.096).  
There was no association between PIH and age, 
educational level, socioeconomic status parity and antenatal 
care in this study.  
The study concluded that PIH adversely affects 
maternal and neonatal outcome.  
Good antenatal care during pregnancy and good 















ﻫﺫﺍ ﺍﻟﺒﺤﺙ ﻴﺩﺭﺱ ﺍﻟﻌﻼﻗﺔ ﺒﻴﻥ ﻀﻐﻁ ﺍﻟﺩﻡ ﺍﻟﻨﺎﺘﺞ ﻋﻥ ﺍﻟﺤﻤل ﻭﺍﻷﺨﻁﺎﺭ ﺍﻟﻤﺘﺭﺘﺒﻪ ﻋﻠـﻰ 
  . ﺍﻟﻤﺸﻴﻤﺔﺼﺤﺔ ﺍﻷﻡ ﻭﻭﺯﻥ 
ﻡ ﻓـﻰ 5002/3/51ﻡ ﺇﻟـﻰ 4002/9/51ﻫﺫﻩ ﺩﺭﺍﺴﺔ ﻤﻘﺎﺭﻨﺔ ﻤﺴﺘﻘﺒﻠﻴﺔ ﻓﻰ ﺍﻟﻔﺘﺭﺓ ﻤﻥ 
ﺃﺜﻨﻴﻥ ﻤﻥ ﺃﻫﻡ ﻭﺤﺩﺍﺕ ﺍﻟﻨﺴﺎﺀ ﻭﺍﻟﺘﻭﻟﻴﺩ ﻓﻰ ﺍﻟﺒﻼﺩ ﻭﻫﻤﺎ ﻤﺴﺘﺸﻔﻰ ﺍﻟـﻭﻻﺩﺓ ﺒﺈﻤـﺩﺭﻤﺎﻥ ﻭﻤﺴﺘـﺸﻔﻰ 
  . ﺍﻟﺭﺒﺎﻁ ﺍﻟﺠﺎﻤﻌﻲ
  . ﻴﻬﺩﻑ ﺍﻟﺒﺤﺙ ﻟﻤﻌﺭﻓﺔ ﺃﺜﺭ ﻀﻐﻁ ﺍﻟﺩﻡ ﺍﻟﻨﺎﺘﺞ ﻋﻥ ﺍﻟﺤﻤل ﻋﻠﻰ ﻭﺯﻥ ﺍﻟﻤﺸﻴﻤﺔ
 ﻤﻥ ﺍﻟﺴﻴﺩﺍﺕ ﺍﻟﺤﻭﺍﻤل ﺍﻟﻼﺌﻰ ﺩﺨﻠﻥ ﻏﺭﻓﺔ ﺍﻟـﻭﻻﺩﺓ ﺒﺎﻟﻤﺴﺘـﺸﻔﻴﺎﺕ ﺠﻤﻌﺕ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ 
  . ﺍﻟﻤﺫﻜﻭﺭﺓ ﺃﻋﻼﻩ ﻭﺘﻤﺕ ﻤﺘﺎﺒﻌﺘﻬﻥ ﺤﺘﻰ ﺍﻟﻭﻻﺩﺓ ﺒﻭﺍﺴﻁﺔ ﺍﺴﺘﺒﻴﺎﻥ ﺃﻋﺩ ﻟﺫﻟﻙ
 ﺤﺎﻟﺔ، ﻨﺼﻑ ﺍﻟﺤﺎﻻﺕ ﻴﻌﺎﻨﻴﻥ ﻤﻥ ﻀﻐﻁ ﺠﻨﻴﻥ  ﻭﺍﻟﻨﺼﻑ ﺍﻵﺨﺭ 061ﺒﻠﻎ ﺍﻟﻌﺩﺩ ﺍﻟﻜﻠﻰ 
  . ﻟﻴﺱ ﻟﺩﻴﻬﻥ ﻀﻐﻁ ﺠﻨﻴﻥ
 ﺴﻨﺔ ﻭﺃﻜﺜﺭ ﻤـﻥ ﻨـﺼﻑ 92-02 ﺘﺘﺭﺍﻭﺡ ﺃﻋﻤﺎﺭﻫﻥ ﻤﺎ ﺒﻴﻥ %( 25)ﺃﻏﻠﺏ ﺍﻟﺴﻴﺩﺍﺕ 
  . ﻤﻥ ﺤﺎﻻﺕ  ﻀﻐﻁ ﺍﻟﺠﻨﻴﻥ ﻤﻥ ﺍﻟﺒﻜﺎﺭﻱ% 23ﺘﺴﻜﻥ ﻓﻰ ﻤﻨﺎﻁﻕ ﺤﻀﺭﻴﺔ، %( 76)ﻋﻴﻨﺔ ﺍﻟﺒﺤﺙ 
ﺨﻠﺼﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻰ ﺃﻨﻪ ﺘﻭﺠﺩ ﻋﻼﻗﺔ ﺒﻴﻥ ﻀﻐﻁ ﺍﻟﺩﻡ ﺍﻟﻨـﺎﺘﺞ ﻋـﻥ ﺍﻟﺤﻤـل، ﻭﻭﺯﻥ 
ﺍﻟﺠﻨﻴﻥ، ﻭﻭﺯﻥ ﺍﻟﻤﺸﻴﻤﺔ، ﻜﻤﺎ ﺘﻭﺠﺩ ﻋﻼﻗﺔ ﺒﻴﻥ ﻀﻐﻁ ﺍﻟﺩﻡ ﺍﻟﻨﺎﺘﺞ ﻋﻥ ﺍﻟﺤﻤل ﻭﺍﻟـﻭﻻﺩﺓ ﺒﻌﻤﻠﻴـﺔ 
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INTRODUCTION AND LITERATURE REVIEW  
 
Pregnancy induced hypertension (PIH): 
Hypertension and/or proteinuria developing after 20 
weeks of pregnancy, during labour or the puerperium in a 
previously normotensive non-proteinuric women. It occurs in 
16-24% of pregnancies and 12-15% of subsequent 
pregnancies. Include:(1)  
a. Preeclampsia:  
Is hypertension associated with proteinuria and 
edema occurring primarily in nulliparas after the 20th 
gestational week and most frequently near term. Recent data 
support the elimination of oedema as a diagnostic criterion.  
b. Eclampsia:  
Is the occurrence of seizures that cannot be attributed 
to other causes in a preeclamptic patients.  
c. Chronic (essential) hypertension:  
Is defined as hypertension that is present before 
conception, before 20 weeks gestation or that persists for 
more than 12 weeks postpartum.  
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Hypertension is defined as blood pressure (BP) equal 
to or greater than 140/90 mmHg or an increase of mean 
arterial pressure to 20 mmHg. The use of an increase in BP of 
30/15 mmHg over first trimester values are controversial. 
Recent data report no increased adverse events in women 
with these changes. However, an increase in BP by this 
amount warrants close observation.  
Proteinuria is defined as the excretion of 300 mg or 
more in a 24 hours urine specimen or 30mg/dl in a random 
specimen.  
d. Superimposed preeclampsia:  
Is preeclampsia occurring in women with chronic 
hypertension, the prognosis is worse for the mother and fetus 
than with either condition alone. The criteria for 
superimposed preeclampsia are worsening hypertension 
(30/15 mmHg) above the average values before 20 weeks 
gestation together with either proteinuria or non dependent 
oedema.  
e. Gestational hypertension:  
Is further divided into transient hypertension of 
pregnancy if preeclampsia is present at the time of delivery 
  3 
and the BP is normal by 12 weeks postpartum, and chronic 
hypertension is the elevation in BP persist beyond 12 weeks 
postpartum. This condition is often predictive of the later 
development of essential hypertension. It is frequently 
difficult to determine whether a patient has preeclmpsia, 
chronic hypertension or chronic hypertension with 
superimposed preeclampsia. This is partly because BP 
normally decreases during second trimester and the decrease 
may mask the presence of chronic hypertension. Renal biopsy 
studies have shown that only about 70% of primigravids 
under 25 years of age with the triad of edema, hypertension 
and proteinuria have glomeruloendotheliosis, the 
characteristic lesion of preeclampsia. 25% have unsuspected 
renal disease. In nulliparas with chronic hypertension with 
superimposed preeclampsia about 3% have glomeruloendo-
theliosis and 21% have under lying renal disease. Renal 
biopsy is rarely performed in pregnancy because the benefits 
rarely justify the risk. The sensitivity and specificity of 
biochemical markers such as uric acid and anti-thrombin III 
are unknown.(2)  
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Predisposing factors to Preeclampsia:  
The predisposing factors to preeclampsia are 
nulliparity, black race, maternal age < 20 > 35 years, low 
socioeconomic status, multiple gestation, hydatiform mole, 
polyhydramnios, non-immune foetal hydrops, diabetic 
patients, chronic hypertension, underlying renal disease.(3)  
Classification:  
There are two categories of preeclampsia: mild and 
severe.  
Severe Preeclampsia:  
Is defined as the following:  
1. Systolic BP >160 mm Hg or diastolic BP >110 
mmHg in two occasions 6 hrs apart.  
2. Proteinuria exceeding 2 g ms in 24 hrs period 
or 2-4+ in dipstick testing.  
3.  Increased serum creatinine >1.2 mg/dl unless 
known to be elevated previously.  
4.  Oliguria < 500 ml/24 hrs.  
5.  Cerebral or visual disturbances.  
6.  Epigastric pain.  
7.  Elevated liver enzymes.  
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8.  Thrombocytopenia < 100.000 mm3.  
9.  Retinal haemorrhages, exudate or papilledema.  
10. Pulmonary oedema.(2)     
Pathogenesis:  
Preeclampsia has been described as a disease of 
theories, because the coarse is unknown. Some theories 
include:  
1. Endothelial cell injury.  
2. Rejection phenomenon (insufficient production 
of blocking antibodies).  
3.  Compromised placental perfusion.  
4.  Altered vascular reactivity.  
5.  Imbalance between prostacycline and 
thromoboxane.  
6. Decreased glomerular filtration rate (GFR) with 
retention of salt and water.  
7.  Decreased intravascular volume.  
8.  Increased central nervous system irritability.  
9. Disseminated intravascular coagulation (DIC).  
10. Uterine muscle stretch (ischemia).  
11. Dietary factors. 
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12. Genetic factors.  
The current hypothesis for the pathogenesis of 
preeclampsia is that an immunologic disturbance causes 
abnormal placental implantation resulting in reduced 
placental perfusion stimulate the production of substances in 
the blood that activate or injure endothelial cells.    
The vascular endothelium provides a single target for 
the blood borne products which explains the multiple organ 
system involvement in preeclampsia.  
 Pathophysiology:  
A. Central nervous system (CNS):  
CNS tissues are capable of regulating their own blood 
flow (autoregulation). Cerebral perfusion is maintained by 
autoregulation at a constant level of about 55 ml/min/100 
gm at a wide range of BP however, BP may rise to levels at 
which autoregulation cannot function, when this occur the 
endothelial tight junctions open causing plasma as red cells 
to leak into the extravascular space. This may result in 
petechial hemorrhages. The upper limit of autoregulation 
varies from one person to another e.g. chronic hypertension 
may cause medial hypertrophy of the cerebral vessels 
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resulting in a shift of the curve to the right. This explain the 
paradox of 2 patients with equally severe hypertension who 
have markedly different clinical presentation. The young 
primigravida whose BP is normally 110/70 mmHg may 
convulse with BP of 180/120 mmHg, while a chronic HT may 
be a symptomatic or have only a headache at the same BP.  
The mechanism of cerebral damage in eclampsia is 
unclear. The pathologic findings are similar to those of 
hypertensive encephalopathy.  
- Fibrinoid necrosis.  
- Thrombosis of arterioles.  
- Micro-infarcts.  
- Petechial hemorrhages.   
In hypertensive encephalopathy and eclampsia the 
lesion were distributed through out the brain, but the brain 
stem is more severely affected in the former, while the cortex 
is more severely affected in the later.  
The presence of cerebral oedema in preeclampsia is 
controversial, one set of researches stated that cerebral 
edema was not present in eclamptic patients when autopsy is 
performed within one hour of death and that such edema was 
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a late postmortem change. In contrast some others found 
generalized cerebral edema in some autopsy specimen and 
confirmed increased intracranial pressure in eclamptic with 
prolonged coma (> 6 hrs).  
Computed tomography scans (CT scan) showed 
abnormalities in one-third of patients with 4th generation CT. 
In patients with seizures abnormalities found in 50% of 
patients (focal hypodensities).  
Magnetic resonant image (MRI) more sensitive in 
demonstrating abnormalities than CT scan.  
Cerebral angiography: performed in few cases of 
eclampsia and revealed diffuse arterial vaso-constriction.  
Electro-encephalography (EEG) show non specific 
abnormalities in 75% of patients after eclamptic seizures, 
usually diffuse slowing activity (theca or delta waves).(2)  
B. Eyes:  
Although visual disturbances are common with severe 
preeclampsia, blindness either alone or accompanying 
convulsion, is not.  
Retinal artery vaso-spasm may also be associated with 
visual disturbances. Fortuitously, Belfort and associates 
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(1992) showed that 6-9 gm bolus of magnesium sulfate 
caused retinal artery vaso-dilatation. Retinal detachment may 
also cause altered vision, although it is usually one sided and 
seldom causes total visual loss as in some women with 
cortical blindness.  
Surgical treatment is seldom indicated, prognosis is 
good, and vision usually returns to normal within a week.(1) 
C. Pulmonary system:  
Pulmonary edema may occur with sever pre-ecempsia 
or eclampsia. It may be cardiogenic or non-cardiogenic and 
usually occurs postpartum. In some cases it may be related 
to excessive fluid administration or to delayed mobilization of 
extra-vascular fluid. It may also be related to decreased 
plasma colloid oncotic from proteinuria, use of cystalloids to 
replace blood loss, and decrease hepatic synthesis of 
albumin.  
Pulmonary edema is particularly common in patients 
with underlying chronic hypertension and hypertensive heart 
disease, which may be manifested by systolic dysfunction, 
diastolic dysfunction or both. Aspiration of gastric content is 
one of the most dreaded complications of eclamptic seizures. 
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This may result in death because of asphyxia from particulate 
mater plugging major airways or chemical pneumonitis from 
aspirated gastric acid. Aspiration may cause various types of 
pneumonia, ranging from patchy pneumonitis to full-blown 
adult respiratory distress syndrome. 
D. Cardiovascular system:  
Plasma volume is reduced in patients with 
preeclampsia, normal physiological volume expansion does 
not occur, possibly because of generalized vaso-constriction, 
capillary leak or some other factors, because the cause of 
reduced volume is unknown management is controversial. 
One theory is that the decreased volume is a primary event 
causing a chronic shock like state. Hypertension is thought 
to be the result of release of a presser substances from the 
hypoperfused uterus or of compensatory secretion of 
catecholamines. Proponents of this theory advocate avoidance 
of diuretics and use of volume expanders. Another theory is 
that decreased volume is secondary to vasoconstriction. 
Proponents of this theory advocate the use of vasodilators 
and warn that volume expander may aggravate hypertension 
or cause pulmonary oedema.(4)  
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Studies using Swan-Ganz catheter have demonstrated 
a spectrum of hemodynamic findings in preeclampsia ranging 
from a low output high resistant state, to high output low 
resistant state.(5)  
Preeclampsia was in general a high cardiac output 
state associated with an in appropriately high peripheral 
resistance.(6)  
The normal wedge and central venous pressure found 
in this study-suggested vasoconstriction with central 
relocation of intravascular volume. If the generally accepted 
reports of decreased plasma volume in preeclampsia are 
correct.  
They postulated splanchnic vasoconstriction as the 
mechanism of this volume shift. Normal pregnant women are 
resistant. To the vasoconstriction effects of anigotensin II. 
Pregnant women required about 21/2 time the amount of 
angiotensin II required by the non-pregnant women to rise 
the diastolic BP 20 mmHg. Patients who will develop 
superimposed preeclampsia lose their refractoriness to 
angiotensin II many weeks before hypertension develops. 
These patients may be identified as early in 18-20 weeks 
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gestation by infusion of angiotensin II.(7) Normal pregnant 
women lose their refractoriness to angiotensin II after 
treatment with prostaglandin synthatase inhibitor such as 
aspirin or endomethacin this suggest that prostaglandin is 
involved in mediating vascular reactivity to angiotensin II in 
pregnancy. Refractoriness to angiotensin II can be restarted 
in patient with preeclampsia by the administration of 
theophllin, a phosphodiesterase inhibitor that increases 
intracellular level of AMP in vascular smooth muscle.(8) 
 Five general observations can be made:  
1.  Myocardial contractility is rarely impaired prior to 
therapy, and ventricular function is usually within the 
normal hyperdynamic range.  
2.  Afterload is elevated in the absence of the therapeutic 
intervention.  
3.  Cardiac output predictably varies inversely with 
vascular resistance and as BP and afterload increases 
cardiac output falls.  
4.  Medication that reduces peripheral resistance such as 
hydralazine increases cardiac output.  
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5. Ventricular pre-load is usually normal or even low in 
severe preeclampsia in the absence of volume expansion.     
E. The liver:  
With sever pre-eclampsia at time there are alteration 
in test of hepatic function and integrity including delayed 
excretion of bromosulfophthalein and elevation of serum 
aspartate aminotransferase levels (AST).(9) 
Severe hyperbillirubinemia is uncommon even with 
severe pre-eclampsia.(10)  
Much of the increases in serum alkaline phosphatase 
is due to heat stable alkaline phosphatase of placental origin. 
Described increased hepatic artery resistance using Doppler 
sonography in 37 women with pre-eclampsia.(11)  
Periportal hemorrhagic necrosis in the periphery of the 
liver lobule is the most likely reason for increased serum liver 
enzymes, such extensive lesions are seldom identified in non-
fatal cases with liver biopsy.(12) Bleeding from these lesions 
may cause hepatic rupture or they may extend beneath the 
hepatic capsule and form a subcapsular hematoma. Such 
lesion without rapture may be more common than previously 
suspected. Using CT scan showed that 5 of 7 women with 
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preeclampsia and upper abdominal pain had hepatic 
hemorrhage. Prompt surgical intervention may be life 
saving.(13)  
F. Kidneys:  
The characteristic lesion of pre-eclampsia, 
glomeruloendotheliosis is the swell of the glomeruli capillary 
endothelium that causes decreased glomerular perfusion and 
GFR.  
Fibrinogen degradation products have been found in 
the basement membrane by some observers, who have 
suggested that intraglomerular coagulation may be secondary 
to thromboplastin released from the placenta. However, the 
fibrinogen degradation products are found infrequently and 
only in small amounts. Other investigations have detected 
immunoglobulins and complements in the glomeruli of some 
patients with preeclmpsia have suggested an immunologic 
mechanism. Renal biopsies have shown that the lesion is to 
become reversible over about 6 weeks. During normal 
pregnancy renal blood flow and GFR are increased. With 
development of preeclampsia serum uric acid is elevated 
especially in women with more sever disease. The elevation in 
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uric acid exceeds the reduction in GFR and creatinine 
clearance that accompanies preeclampsia. Despite this 
plasma uric acid measurement are generally of little practical 
value for diagnosis, management and prognosis. Plasma uric 
acid values can also be elevated by thiazides diuretics.(14)   
In the majority of severe preeclampsia women mild to 
moderately diminished GFR appears to results from a 
reduced plasma volume resulting in plasma creatinine value 
approximately twice those expected for normal pregnancy of 
about 0.5 mg/dl in severe case of preeclampsia. However, 
renal involvement is profound and plasma creatinine may be 
elevated several times over the non-pregnant normal values 
or up to 2-3 mg/dl. This is likely due to intrinsic renal 
changes caused by sever vasospasm because total renal 
perfusion does not appear to be reduced in preeclamptic 
women.(15)  
G. Blood:  
Most patients with preeclampsia have normal clotting 
studies. In some, a spectrum of abnormal may be found 
ranging from isolated thrombocytopenia to microangiopathic 
hemolytic anemia to DIC.  
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Thrombocytopenia is the commonest abnormality, 
account of less than 150.000/ml is found in 15-20% of 
patients. Fibrinogen levels are actually elevated in 
preeclamptic women as compared with normotensive 
patients. Low fibrinogen level in patients with preeclampsia 
are usually associated with abraptio-placentae or fetal 
demise.  
Elevated fibrin split products are seen in many 
patients.  
The HELLP syndrome described patients with 
hemolytic anemia, elevated liver enzymes and low platelet 
count.  
Criteria for the diagnosis at the author's institution 
are schistocytes on peripheral blood smear, lactic 
dehydrogenase >600 u/L  total bilirubin 70 u/L and platelets 
count <100.000/mm3. This syndrome is present in about 
10% of patients with sever pre-eclampsia. It is frequently 
seen in Caucasian patients with abruptio-placentae. The 
syndrome may occur remote from term, and with no elevation 
of blood pressure. The syndrome is frequently misdiagnosed 
as hepatitis, gall-bladder disease, idiopathic 
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thrombocytopenia purpura. Most hematologic abnormalities 
return to normal within 2-3 days after delivery, but 
thrombocytopenia may persist for a week.  
H. Endocrine system:  
The role of renin-angiotensin-aldosterone system in 
the regulation of BP during normal and hypertensive 
pregnancy has not been clearly defined. Their levels were 
increased in normal pregnancy and are lowered close to 
normal in patients with preeclampsia atrial natriuretic 
peptide (ANP), is a volume regulatory hormone synthesized by 
cardiac myocytes, which has potent natriuretic, diuretic and 
vasorelaxant properties. ANP secretion is stimulated by 
increased atrial pressure and alteration in sodium balance. It 
is elevated in preeclampsia, a disorder supposedly 
characterized by hypovolemia. It is even elevated in the 2nd 
trimester before the onset of clinical evidence of 
preeclampsia. The mechanism for elevation is unknown, so it 
may be that the widely accepted concept of central 
hypovolemia in preeclampsia is incorrect.  
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I. Catecholamines:   
Levels are the same in normotensive pregnant women, 
and women with preeclampsia and non-pregnant controls.  
 J. Prostacycline:  
Is a prostaglandin made in the endothelial cells from 
arachidonic acid catalyzed by cyclooxyenase. It increases 
AMP in smooth muscle cells and platelet resulting in 
vasodilator and platelet antiaggregatory effects. Thromboxane 
A2 generated by platelets from arachidonic acid via 
cyclooxygenase induces vasoconstriction.  
Aspirin inhibits irreversibly cyclooxygenase. 
Cyclooxygenase must be produced continuously by 
endothelial cells, because they recover their ability to 
synthesize prostacycline within few hours after dose of 
aspirin. On the other hand platelet do not have a nucleus and 
there fore cannot make fresh cyclooxygenase.  
Thromboxane synthesis recovers only as new platelet 
enters the circulation platelet life span is about 1 weeks, thus 
daily treatment with low dose aspirin result in chronic 
inhibition of thromboxane metabolites and decreased 
excretion of prostacycline metabolites in preeclamptic 
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patients. Low dose aspirin therapy is aimed at restoring the 
presumed thromoxane-prostacycline imbalance in 
preeclampsia.  
K. Nitric oxide:  
Nitric oxide (NO) is an endogenous vasodilator an 
inhibitor of platelets aggregation and act synergistically with 
prostacycline. Currently it is thought that the NO system may 
be more important than prostaglandin in the pathogenesis of 
preeclampsia.  
L. Endothelin-I:  
In addition to the relaxing factors prostacycline and 
NO, the vascular endothelium releases vasoconstrictor 
substances, there are three different isopeptides endothelin 
1,2,3. Endothelin-I is the only endothelin synthesized by 
endothelial cells. The most striking property of endothelin, is 
it's long lasting vasoconstrictor action. It is 10 times more 
potent than angiotensin II. Endothelin -I may play a role in 
constriction of placental vessels after delivery. A three fold 
elevation of plasma endothelin 1 & 2 has been found in 
women with preeclampsia compared with gestation matched 
controls. One hypothesis is that prostacycline is an 
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antiplatelet and vasodilator mechanism held in reserve to 
reinforce the NO system when endothelial damage occurs. 
Lack of NO may be causative factor in hypertension. 
Endothelin-I is released by endothelial cells to constrict the 
underlying smooth muscles in an emergency such as 
laceration.   
M. Placenta:  
In normal pregnancy, the proliferating trophoblast 
invade the decidua and the adjacent myometrim in two 
forms: interstitial and endovascular the role of interstitial, is 
not clear but it may serve to anchor the placenta. The 
endovascular trophoblastic cells invade the maternal spiral 
arteries, where they replace the endothelium and destroy the 
medial elastic and muscular tissue of the arterial wall. The 
arterial wall is replaced by fibrinoid material this process is 
complete by the end of the first trimester, at which time it 
extends to the decidumyometrial junction. There appear to be 
a resting phase in the process until 14 to 16 weeks gestation, 
when a second wave of trophoblastic invasion extends down 
the lumen of the spiral arteries to their origin from the radial 
arteries deep in the myometrium. The same process is then 
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repeated i.e. replacement of the endothelium destruction of 
the medial muscloelastic tissue, and fibrinoid change in the 
vessel wall. The end result is that the thin walled muscular 
spiral arteries are converted to saclike, flaccid utero-placental 
vessels, which passively dilate to accommodate the greatly 
augmented blood flow required in pregnancy.  
Preeclampsia develops following a partial failure in the 
process of placentation. First not all the spiral arteries are 
invaded in the first phase of trophoblastic invasion occurs 
normally, but the second phase does not occur, and the 
myometrial portions of the spiral arteries retain their reactive, 
musculoelastic wall. In preeclampsia the arteries show 
atherosis in the myometrial portion of the spiral arteries. So 
in preeclampsia we ended with an area or vascular resistance 
due to failure of invasion and atherosis, compromises the 
vascular lumen leading to intrauterine growth retardation 
(IUGR) or stillbirth.  
N. Fluid and electrolyte changes:  
The volume of extra cellular fluid in women with sever 
preeclampsia-eclampsia has expanded beyond the normally 
increased volumes that is characterized pregnancy. The 
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mechanism responsible for the pathological expansion is not 
clear oedema is evident at a time when paradoxically, 
aldosterone levels are reduced compared with markedly 
elevated levels of normal pregnancy, however, plasma deoxy-
corticosterone remain elevated. Following an eclamptic 
convulsion, the bicarbonate concentration is lowered due to 
lactic acidosis and compensatory respiratory loss of carbon 
dioxide (CO2).  
Clinical findings:   
A. Symptoms and signs: 
• Hypertension:   
Is the most important criterion for the diagnosis of 
preeclampsia. Any increase of blood pressure by 30/15 
mmHg should be considered ominous. The BP is often labile. 
It usually fall during sleep in patients with mild 
preeclampsia. But in patients with severe preeclampsia BP 
may increase during sleep e.g. the most severe hypertension 
may occur at 2:00 am.(4)   
• Proteinuria:   
Is the last sign to develop, eclampsia may occur 
without proteinuria. Most patients with proteinuria will have 
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glomeruloehdotheliosis on kidney biopsy. Protein in 
preeclampsia is an indicator of foetal jeopardy, risk of small 
for gestational age (SGA) and perinatal mortality increased in 
patients with proteinuric preeclampsia.(16)  
• Oedema:  
Previously a weight gain of more than 2 Ib/week or 
sudden weight gain over 1 to 2 days was considered 
worrisome. However, oedema is a common occurrence in 
women with normal pregnancy, and preeclampsia may occur 
in women without edema. The use of oedema as a defining 
criterion for preeclampsia is controversial and most recent 
reports omit it from the definition.(17) 
• Crisis:   
Preeclampsia-eclampsia is a multisystem disease with 
varying clinical presentation. One patient may present with 
eclamptic seizures another with liver dysfunction and IUGR, 
another with pulmonary oedema, still another with abruptio-
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B. Laboratory findings: 
• Hemoglobin and hematocrit increased may be due to 
hemo-concentration or in more severe cases there may be 
anemia due to hemolysis.  
• Low platelets.  
• Fibrin splint products and decreased coagulation factors 
may be detected.  
• Serum uric acid usually elevated above 6 mg/dl.  
• Serum creatinine is most often normal (0.6 - 0.8 mg/dl) 
but may be elevated in severe preeclampsia.  
• Although hepatic abnormalities occur in about 10% of 
patients. The bilirubin is usually below 5 mg/dl and the 
aspartate aminotransferase (AST) below 500. Alkaline 
phosphatase may increase 2-3 folds. Lactate delydrogenase 
may be quite high (because of hemolysis or liver injury).  
• Blood glucose and electrolytes are normal.  
• Urinalysis reveals proteinuria and occasionally hyaline 
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Complications:   
• Preterm labour.  
• Fetal complications due to prematurity.  
• Acute and chronic uteroplacental insufficiently leading 
to intrapartum fetal distress or stillbirth.  
• IUGR.  
• Oligolydrumnios.  
Prevention:  
• Features of PE:  
PIH, protein-uria, generalized edema, 
hyperuricaemia, increased hematocrit, thrombocytopenia, 
reduced anti-thromboin III, abnormal liver function test (LFT), 
hypocalcaemia, raised cellular fibronectin, vonWillebrand 
factor, abnormal uterine artery Doppler waveform.(19)  
Foetal syndrome:   
- Foetal growth retardation.  
- Abnormal artery doppler waveform.  
- Foetal hypoxaemia.  
Several interventions have been used in attempt to 
reduce incidence of PE in high-risk women. This include:  
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A. Calcium supplementation: 
It is known that the incidence of PE is lower in 
populations with a diet high in calcium.  
Initial studies in countries whose dietary calcium is 
low suggested that calcium supplementation reduced the risk 
of preeclampsia.(20)  
B. Aspirin: 
Aspirin inhibit the synthesis of prostaglandins by 
inactivating cyclooxygenase. Platelets cyclooxygenase is more 
sensitive to inhibition by low dose of aspirin (< 100 mg). Than 
endothelial cyclooxygenase, and therefore, treatment increase 
the prostacyclin to thromboxane ratio. There was a 12% 
reduction in incidence of PE by low dose aspirin. Low dose 
aspirin does not appear to be associated with an increase in 
risk of postpartum hemorrhage. Most clinicians continue to 
use aspirin from 12 weeks of pregnancy in women at risk of 
early onset PE i.e. with chronic hypertension, renal disease 
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C. Fish oil: 
Marine n-3 fatty acids are known to reduce the 
formation of thromboxane A2 with little or no effect on 
prostaglandin.(21)  
Management: 
• Investigations:  
Women who have a diastolic BP ≤ 90-mmHg need no 
further assessment unless there is significant proteinuria, 
severe hypertension or symptoms suggestive of PE. The 
principal aim for assessment is early recognition of PE with 
the expectation that increased laboratory and ultrasound 
(U/S) surveillance and timely intervention can reduce the risk 
of maternal and foetal complications.(15)  
• The objectives in management are as follows:  
- Prevention of complications such as 
pulmonary oedema, renal failure, 
cardiovascular accidents and abruptio-
placentae.  
- Prevention of convulsions as this is associated 
with 10 times increased risk in maternal 
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mortality as well as increased risk in perinatal 
mortality.  
- Delivery of a healthy neonate with minimum 
maternal morbidity.(22) 
Suggested management of severe pre-eclampsia at 
various gestational age:  
• ≤ 24 weeks → stabilize the patient → termination of 
pregnancy.  
• 25-32 weeks = expectant management → deliver 
according to maternal or neonal indications.  
• >32 weeks → stabilize-deliver. 
•  2 & 3 extensive maternal and foetal surveillance.(23)     
Antihypertensive therapy: 
The role of antihypertensive therapy in women with 
mild to moderate PIH is controversial. It reduce the incidence 
of severe hypertension and also hospital admission.  
There is some evidence that antihypertensive therapy 
in women with mild PIH (diastolic BP 95 mm Hg), started 
around 34/52 gestation can significantly reduce the rate of 
subsequent proteinuria as well as reducing hospitalization.(24) 
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Antihypertensive drugs used to treat hypertension in 
pregnancy will only prevent those complications directly 
related to maternal hypertension. Arterial injury occur above 
mean arterial BP of 140 mmHg in cerebral circulation this is 
associated with loss of auto-regulation and increase risk of 
cerebral hemorrhage. The aim should be to keep BP below 
160/110 mmHg and treatment is therefore indicated if 
readings repeatedly reach this level.  
Any drug used for the acute treatment of severe 
hypertension can precipitate fetal distress and therefore 
continuous fetal monitoring is mandatory until blood 
pressure has been stabilized.(25) 
Treatment of high blood pressure reduce the risk of 
severe hypertension, but there is no evidence that reduces BP 
reduce other aspects of disease progression. This possible 
maternal benefit has to be balanced against the risk that 
reducing BP may reduce placental perfusion, which can 
cause foetal distress, particularly in compromised foetuses. 
Antihypertensive drugs are mainly indicated in severe 
hypertension (160/100 mmHg) with the aim of preventing 
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cerebral hemorrhage in the mother. But has not been shown 
to improve fetal morbidity or mortality.  
Prevention of PE remain the aim challenge, whereas 
antihypertensive drugs are ineffective, calcium 
supplementation and low dose aspirin have proven effective, 
but mainly in selected cases with a relatively high incidence 
of PE (> 8 - 10%).(26)  
In multiparas the selection of such high-risk 
population is relatively easy when at least 2 or 1 of previous 
pregnancies were complicated with early preeclampsia and/or 
intrauterine growth retardation. In nulliparas the selection of 
high-risk population is still a subject of research. The two 
most promising criteria are abnormal Doppler velocity of 
uterine arteries at around 20 weeks gestation and abnormal 
high levels of βHCG at 17 weeks, of amenorrhoea. 
Acute treatment of sever hypertension: 
• Hydralazine 5 mg I.V bolus repeated every 20-30 min, it 
is found to reduce the mean arterial pressure (MAP) by           
10-15 mmHg.  
• Labetalol 20 mg I.V bolus repeated in an increasing dose 
at interval of 10-15 min.  
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• Nifidepine 10 mg per oral repeated at interval of 30 min.  
• Sodium nitroprusside 0.25 mg/kg/min, I.V infusion 
increased by 0.25 mg/kg/min every 5 min.  
• Nitroglycerine 10 mg/min in infusion doubling dose 
every 5 min.(27)  
Long term treatment of hypertension: 
•  Methyldopa 1 gm load then 1-2 gm per day in three 
divided doses to a maximum of 3 gms/day.  
•  Labetalol 300 mg in there divided closes to a 
maximum of 1200 mg/day.  
•  Nifidepine 40 mg/day in two divided doses to a 
maximum of 120 mg/day.  
•  Hydralazine 100 mg/day in four divided doses to a 
maximum of 300 mg/day.(28)     
In-patient care: 
The definitive treatment of PE is delivery. Once the 
diagnosis has been made the patient should be admitted. The 
frequency of maternal and fetal monitoring will depend on the 
results of initial investigations. In most women with normal 
results, a full blood count, urea and electrolytes, LFT can be 
repeated twice weekly with weekly estimation of 24 hours 
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protein excretion.(29) If umbilical artery Doppler and amniotic 
fluid volumes are normal these can be repeated weekly. More 
frequent monitoring is appropriate if either is abnormal or 
there are concerns about fetal growth. Loss of Doppler end 
diastolic frequencies in the umbilical artery is a particularly 
ominous sign.(29)  
A decelerate heart pattern can be anticipated within 
two weeks of this findings and therefore, daily monitoring by 
either biophysical profile or if not available continuos fetal 
heart monitoring is mandatory.(30)   
Delivery:  
Hypertension disorders are the second commonest 
indication for induction of labour after post date. Isolated PIH 
is rarely if ever an indication of preterm delivery unless sever 
hypertension can not be controlled with antihypertensive 
therapy.(31) 
Most induction of labour are undertaken of mild PIH 
and up to 2/3 of women admitted with no proteinuria.  
Hypertension at 37 weeks gestation and whether mild 
uncomplicated PIH is an appropriate indication for labour 
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induction before 41 weeks gestation particularly in 
primigravida with an unfavorable cervix in arguable.(32)   
 
 
Indication for delivery: 
Providing the foetal and maternal conditions are 
satisfactory expectant management should be continued to 
37-38 weeks.  
Deferring delivery beyond this gestation confers no 
benefits to the infant, while increasing the risk of 
deterioration in the maternal and/or foetal condition.(33)  
The indications for preterm delivery are:  
•  Sever uncontrolled hypertension (≥160/110 mmHg). 
•  Hemolysis with thrombocytopenia and elevated AST.  
• Progressive symptoms (headache, visual 
disturbances, epigastric pain).  
•  Pulmonary oedema.  
•  Renal compromise with oliguria.  
•  Eclampsia.  
•  Foetal compromise (diagnosed by biophysical profile 
or foetal heart rate monitoring).  
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•  Progressive thrombocytopenia.  
•  Foetal growth restriction with oligohydramnios.  
•  Absent or reversal end diastolic frequencies in the 
umbilical artery. If preterm labour is anticipated 
corticosteriods should be given to accelerate foetal 
pulmonary maturation.(18)  
The management of preeclampsia presenting in the 
second trimester is particularly difficult. Perinatal survival is 
2% when the disease develops before 24 weeks and 
termination of pregnancy should be considered.(34)  
Presentation between 24-27 weeks result in immediate 
delivery in about one-third of cases (perinatal survival 
24.4%). While conservative management with daily evaluation 
of maternal and foetal wellbeing is possible in the remainder 
(perinatal survival 65%).(35)  
Management of labour and delivery: 
Delivery:  
The mode of delivery is determined by the gestational 
age, state of the cervix and foetal condition.  
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The chances of successful induction of labour are low 
in primigravida with unfavourable cervix at >34 weeks 
gestation.(34)  
Even if induction is successful in this group, 
emergency caesarean section becomes necessary in up to 
45% of cases because of fetal intolerance of labour. A high 
proportion of such cases are therefore delivered by caesarean 
section without an attempt at induction. Particularly when 
delivery need to be expedited quickly because of concerns 
about maternal condition.(35)  
Prolonged pushing increases mean arterial pressure 
(MAP) by 50 mmHg and should be avoided. Dangerous 
hypertension can also be precipitated by administration of 
ergometrine, syntocinon should therefore be used in the 
management of the 3rd stage of labour in women with 
hypertension.(36)    
Fluids monitoring: 
Fluid management is important in severe PE because 
the low plasma volume and cardiac output increase the 
likelihood of foetal distress and oliguria, particularly after 
vasodilatation. However, endothelial damage, low oncotic 
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pressure and excessive fluid administration increase the risk 
of pulmonary edema. Women with severe PE are less tolerant 
to hemorrhage and blood transfusion should be initiated 
earlier than in normotensive women.(15)  
 
 
Principles of fluid management: 
•  Accurate recording of fluid balance (including 
delivery and postpartum blood loss). 
•  Maintenance crystalloid infusion (1 litre ringer 
lactate 12 hourly). 
•  Selective monitoring CVP-oligurial urine output 
<100 ml/4 hrs.  
•  Haemorrhage.  
•  Selective colloid expansion prior to arterial 
vasodilatation in oliguria with low CVP (4 mm Hg).  
• Diuretics use confined to women with pulmonary 
edema.(27)   
Analgesia and anaesthesia: 
•  Epidural block is the preferred method of analgesia. 
Pain relief is optimal, blood pressure control is 
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facilitated and placenta blood flow may be increased. 
This techniques is contra-indicated if there is DIC or 
thrombocytopenia. Epidural block is also the optimal 
method of anaesthesia for caesarean section unless 
delivery is urgent.  
•  General anaesthesia may be associated with difficult 
or failed intubation, due to laryngeal edema, and 
intubation causes transient but marked 
hypertension, which can not reliably controlled by 
antihypertensive therapy.  
•  Spinal anesthesia is probably contraindicated 
because of sever hypotension. Hypotension can 
occurs with epidural anesthesia but adequate fluid 
preloading and use of incremental bupivacaine 
minimize this risk.(37) 
Postnatal counselling: 
Twenty-five to 30% of women with PIH in their first 
pregnancy will have recurrent hypertension in subsequent 
pregnancy.(38) if the first pregnancy is complicated by PE the 
risk of recurrence is 7-10%. If PIH complicated by eclampsia 
or HELLP syndrome the recurrence is 20 - 30%.  
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Women with PE appeared to be at increased risk of 
death from cardiovascular disease.(39) If blood pressure 
returned to normal postnatally there is no contraindication to 
oral contraceptive.(40)  
Puerperal tubal ligation should be avoided because of 
the attendant risk of thrombo-embolic diseases and 
pulmonary embolism.(41)         
At the 6th weeks postnatal assessment, the presence of 
hypertension or proteinuria necessitates referral to physician 
for further investigations.  
Early booking and follow-up and low dose aspirin.(41)  
Complications of severe preeclampsia: 
• Eclampsia:  
Is the occurrence of convulsions in association with 
the features of PE. the incidence is 4.9/10.000 maternaties 
the maternal case fatality is 1.8% and 35% of women will 
have at least one major complication of seizures.  
Percentage of eclampsia:(42)  
44% postpartum.  
38% antepartum.  
18% intrapartum.   
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The pathophysiology is thought to be cerebral 
vasospasm leading to ischemia and cerebral oedema.(43)  
Diagnosis: 
Eclamptic seizures classically occurs in the second 
half of pregnancy and up to 10 days after delivery. They are 
tonic-clonic in nature being followed by brief period of coma. 
Many women manifest excitability or hyperreflexia prior to 
the onset of seizures.(35)  
The diagnosis of eclampsia is straightforward when 
convulsions occurs in women with PE. However, 38% do not 
have established proteinuria and hypertension before the first  
fit and less than 60% antecedent symptoms. The diagnosis is 
more difficult if the women is found unconscious persistent 
coma or development of localizing signs should raise the 
possibility of cerebral accident.(42)     
Symptoms and signs of impending eclampsia: 
- Sever frontal headache.  
- Epigastric pain.  
- Nausea and vomiting.  
- Blurring of vision.  
- Hyper-reflexia, sustained clonus.(35)  
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Principles of management of eclampsia: 
1.  Immediate care:  
- Maintain airway.  
- Left lateral position.  
- Oxygen administration.  
2.  Abort convulsions:   
- Diazepam 10 mg I.V.  
- Clonazepam 1 mg I.V.(44)  
3.  Seizures prophylaxis:   
- Magnesium sulfate.   
4.  Maintain diastolic pressure of 95-105 
mmHg.  
5.  Coagulation screen/renal 
function/platelet count.  
6.  Hemodynamic stabilization followed by 
delivery within 6-8 hrs.  
7.  Postpartum 24-48 hrs intensive care.  
8.  Ventilatory support for at least 24 hrs if:   
- Poor arterial blood gases.  
- Unconsciousness, Glasgow coma scale < 
8. 
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- Extreme restlessness.  
- Laryngeal edema.(43)  
Mode of delivery: 
Caesarean section is recommended in the following 
situations:  
-  All deeply unconscious patients (unless 
delivery is imminent).  
-  All uncooperative patients: 
-  If vaginal delivery is unlikely to occur within 6-
8 hrs from the onset of first eclamptic seizures.    
-  There is an obstetrical indication for caesarean 
section.  
-  Foetal distress.    
If the patient delivering vaginally, one should assist 
the second stage of labor in order to avoid the raise in 
maternal blood pressure with each uterine contraction, 
further more ergometrine is contraindicated in 3rd stage of 
labour.(34) 
Contraception: 
- Steroidal contraception can be prescribed.  
- Tubal ligation should be avoided.(42)  
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 Postnatal assessment: 
At 6th weeks postpartum the presence of hypertension 
or proteinuria necessitate referral to physician.  
Pregnancy should be advised only if BP and renal 
function test return to normal. It is important to counsel the 
patient on booking early in the future pregnancies. So 
administration of low dose aspirin as early detection or PE 
become possible.(34) 
 
Pulmonary oedema and acute renal failure: 
Pulmonary oedema occurs in 1-2% of women with 
sever preeclampsia. Treatment involves I.V frusamide (40 mg 
initially) and oxygen. Persisting hypoxemia is particularly 
concerning and justifies intensive care.(33)    
Acute renal failure also complicate 1-2% of severe 
cases with dialysis being required in half.  
Renal failure may co-exist with pulmonary edema and 
both are associated with abruptio-placentae, hemorrhage and 
DIC.  
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Death has been reported in around 10% of cases, 
often reflecting multiorgan failure, but renal function return 










1.  To assess the placental weight in PIH.  
2.  To assess fetal weight in PIH.     
 
 
    
 
 












PATIENTS AND METHODS  
Study design and area:  
A multicenters case control study, conducted at two 
maternity units in Omdurman Maternity Hospital (the main 
separate maternity hospital in Sudan) and Ribat National 
Hospital. These hospitals received patients from all Khartoum 
State and country side.  
Study period:  
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The study was conducted in the period from 15th of 
September 2004 to 15th of March 2005.  
Subjects: 
Women who came to the labour wards with PIH were 
selected to the study, regardless of their gestational age or 
mode of delivery.  
Informations were gathered by direct interview to the 
women using pre-designed questionnaire, which include 
informations about the personal history, intrapartum and 
postpartum.  
The interview was done by the researcher himself (who 
measured placental weight, foetal weight and blood pressure 
on admission).  
Sample size: 
The hundred and sixty women were selected randomly 
for the study. The placental weight was measured in the same 
way after delivery of the baby.  
Data analysis 
This informations were subjected to computer using 
Stata Five (Statistical Package).  
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The Fisher's exact test was used for comparing two 
variables, significant test of Fisher's exact ≤ 0.05 and 
marginally significant test at Fisher's exact ≤ 0.10. Mean of 
the placental weights were determined.   









One hundred-sixty patients were collected to the study 
randomly from all women presented to the labour room 
during the period of the study. Eighty cases and eighty 
control.  
Regarding the age of the study groups, 67.5% of 
control and 52.5% of cases were between 20-29 years of age, 
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31.25% of control and 45% of cases were more than 30 years 
of age and negligible percentage below 20 years of age        
(Fig. 1). 
Eighty five percent of control group and 60% of the 
cases were from urban areas and the others from rural area 
(Fig. 2).  
Concerning educational level, 32.5% of the cases and 
33.75% of the control group were illiterate, 58.75% of the 
cases and 52.5% of the control group were completed their 
primary or secondary school and only 8.75% of case and 
13.75% of control group were at or completing their 
university level  (Fig. 3).  
Regarding the socioeconomic status, 76.25% of cases 
and 66.25% of the control group were from low class, 20% of 
cases and 27.5% of control group were from moderate class 
and only small percentage from high class (Fig. 4).  
Regarding parity, 32.5% of cases and 37.5% of control 
group were nuliparous, 52.5% of cases and 50% of control 
group were range from para one to para four and 15% of 
cases and 12.5% of control group were delivered more than 
four times (Fig. 5).  
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About antenatal care attendance during pregnancy, 
55% of cases and 63.75 of control group had regular 
antenatal care, 33.75 of cases and 30% of control group had 
irregular antenatal care, whereas 11.5% of cases and 6.25% 
of control group had no antenatal care (Fig. 6).  
Regarding past history of PIH, 23.75% of cases had 
past history of PIH (Table I).  
Concerning past history of IUGR, 16.25% of cases had 
past history of IUGR (Table II).  
Regarding use of antihypertensive drugs to control 
blood pressure, 28.75% of cases had used antihypertensive 
drugs (Fig. 7). 
Oligohydraminios complicates 7.5% of cases (Fig. 8)   
Concerning diastolic blood pressure in admission, 
20% of cases had diastolic blood pressure <100 mm Hg, 
67.5%  of cases had diastolic blood pressure between 100 -
110 mm Hg, 12.5% had diastolic blood pressure of > 110 
mmHg (Fig. 9).   
Regarding past history of chronic hypertension, 10% 
of cases had past history of chronic hypertension (Fig. 10).  
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Regarding past history of antiphospholipid syndrome, 
1.25% of cases had the syndrome (Fig. 11). 
Regarding mode of delivery, 13.75% of cases and 
96.25% of control group were delivered vaginally 
(spontaneously) whereas 11.25% of cases and 3.75% of 
control group ended with induced vaginal delivery and 75% of 
cases delivered by C/S (Table III).  
Ten percent of cases ended with stillbirth deliveries, 
whereas 90% of cases and 100% of control group ended with 
live births (Table IV). 
About foetal weight, 15% of cases had birth weight 
<1.5 kg, whereas 41.25% of cases and 25% of control group 
had birth weight between 1.5- 2.5 kg. Also 43.75% of cases 
and 75% of control group had birth weight >2.5kg (Table V). 
Regarding the need for neonatal resuscitation 23.75% 
of cases and 2.5% of control group had offered neonatal 
resuscitation, whereas 76.25% of cases and 97.5% of control 
group didn't need neonatal resuscitation (Table VI).  
Regarding Apgar score at 5 minutes, 68.75% of cases 
and 100% of control group had Apgar score of ≥7, whereas 
31.25% of cases had Apgar score <7 (Table VII). 
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About 23.75% of neonate in the cases were admitted 
to the Neonatal Intensive Care Unit, whereas 76.25% of cases 
and 100% of control group need no admission (Table VIII).  
Regarding placental weight, 16.25% of cases had 
placental weight < 400 gm, 55% of cases and 48.75% of 
control group had placental weight between 400 - 500 gm, 
whereas 28.75% of cases and 51.25% of control group had 
placental weight >500 gm (Table IX).  
Table X shows only 1.25% of cases had past history of 
syphilis, while 98.75% of cases and 100% of control group 
denied any past history of syphilis.  
Table XI shows correlation between foetal outcome 
and gestational age, in cases at less than 28 weeks, 5.5% 
were alive and 50% were stillbirths, between 28 and 34 
weeks, 62.5% were alive and 12.5% were stillbirths, and more 
than 34 weeks 32% were alive and 37.5% were stillbirths.  
Table XII shows correlation between foetal weight and 
placenta weight, 75% with placental weight <400g, 25% of 
placental weight between 400 - 500gm had babies with 
<1.5kg in weight. While 12.12% with placental weight < 400 
gm, 78.79 with placental weight between 400 and 500 gm 
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and 9.09% with placental weight more than 500 gm had 
babies with weight between 1.5 - 2.5kg, while 42.86% with 
placental weight between 400 - 500 gm and 57.14% with 
placental weight >500 gm had babies with >2.5 kg in weight 
among the cases.  
Table XIII shows the correlation between foetal 
outcome and placental weight. With placental weight <400 
gm had 12.5% of alive babies and 50% of stillbirth babies in 
the cases, while placental weight between 400 - 500 gm had 
55.56% of alive babies and 50% of stillbirth babies in the 
cases, while placental weight >500 gm had 31.94% of alive 
babies in the cases.  
Table XIV shows there was no correlation between 
placental weight and proteinuria among the cases.  
Table XV shows correlation between placental weight 
and foetal weight in weight of >2.5kg or ≤ 2.5kg, 42.86% of 
babies with placental weight between 400 - 500 gm and 
57.14% of babies with placental weight >500 gm had babies 
>2.5 k in weight.    
Table XVI shows correlation between placental weight 
and need for neonatal resuscitation among the cases group, 
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100% of babies with placental weight < 400 gm and 10% of 
babies with placental weight between 400 - 500 gm had 
neonatal resuscitation, while no baby with placental weight 
>500 gm had neonatal resuscitation.  
Table XVII shows correlation between placental 
weight and Apgar score at 5 minutes of babies among the 
cases, no baby with placental weight <400 gm, 56.6% of 
babies with placental weight between 400 - 500 gm and 
43.4% of babies with placental weight >500 gm had an Apgar 
score ≥ 7, while 48.1% of babies with placental weight <400 
gm and 51.9% of babies with placental weight between 400 - 
500 fm and no baby with placental weight >500 gm had an 
Apgar score < 7.  
Table XVIII shows correlation between foetal weight 
and placental weight in babies with gestational age >34 
weeks, 33.3% of babies with placental weight between 400 - 
500 gm, and 66.7% of babies with placental weight >500 gm 
had foetal weight >2.5 kg.  
  
   
  

















Table I: Past history of pregnancy induced  
hypertension among the study group   
Past history of PIH Type  
Yes  No  
Total  
Control  0 (0.0%) 80 (100%)  80 (100%) 
  54 
Case  19 (23.75%)  61 (76.25%)  80 (100%) 
 
Fisher's exact test = 0.001 













Table II: Past history of intrauterine growth restriction 
among of the study group  
Past history of IUGR Type  
Yes  No  
Total  
Control  0 (0.0%) 80 (100%)  80 (100%) 
  55 
Case  13 (16.25%)  67 (83.75%)  80 (100%) 
 
Fisher's exact test = 0.001 













 Table III: Mode of delivery among the study group   
 
Mode of delivery  Type  
NVD  Induction  C/S 
Total  
Control  77 (96.25%) 03 (3.75%)  0 (0.0%)  80 (100%)  
  56 
Case  11 (13.75%)  9 (11.25%)  60 (75%) 80 (100%)  
 
















Table IV: Distribution of foetal outcome among 
 the study group   
Type  Foetal outcome  Total  
  57 
Alive  Stillbirth 
Control  80 (100%)  0 (0.0%)  80 (100%) 
Case  72 (90%)  8 (10%)  80 (100%) 
 
Fisher's exact test = 0.007 












Table V: Foetal weight among the study group   
 
Foetal weight ( in kg)  Type  
< 1.5 1.5 - 2.5  >2.5 
Total  
  58 
Control  0 (0.0%) 20 (25%)  60 (75 %)  80 (100%)  
Case  12 (15%)  33 (41.25%)  35 (43.75%) 80 (100%)  
 















Table VI: Need for neonatal resuscitation among 
 the study group   
Type  Resuscitation  Total  
  59 
Yes  No  
Control  2 (2.5%)  78 (97.5%)  80 (100%) 
Case  19 (23.75%)  61 (76.25%)  80 (100%) 
 
Fisher's exact test = 0.001 













Table VII:  Apgar score at 5 minutes among 
 the study group   
Type  Apgar score  Total  
  60 
≥ 7 <7 
Control  80 (100%)  0 (0.0%)  80 (100%) 
Case  61 (76.25%) 19 (23.75%)  80 (100%) 
 
Fisher's exact test = 0.001 













Table VIII: Need for neonatal intensive care unit 
admission among the study group   
Type  Admission to NICU Total  
  61 
Yes  No  
Control  0 (0.0%)  80 (100%) 80 (100%) 
Case  19 (23.75%)  61 (76.25%)  80 (100%) 
 
Fisher's exact test = 0.001 













Table IX: Distribution of placental weight 
 among the study group   
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Placental weight  (in grams)  Type  
< 400 400 - 500 > 500 
Total  
Control  0 (0.0%) 39 (48.75%)  41 (51.25 %)  80 (100%)  
Case  13 (16.25%)  44 (55%)  23 (28.75%) 80 (100%)  
 













Table X: Distribution of past history of syphilis     
among the study group   
Type  Past history of syphilis Total  
  63 
Yes  No  
Control  0 (0.0%)  80 (100%) 80 (100%) 
Case  1 (1.25%)  79 (98.75%)  80 (100%) 
 
Fisher's exact test = 1.000. 













Table XI: Correlation between foetal outcome and 
gestational age among cases   
 
  64 
Gestational age (in weeks)  Foetal 
outcome  < 28  28 - 34  > 34 
Total  
Alive  4 (5.5%) 45 (62.5%)  23 (3.2 %)  72 (100%)  
Stillbirth  4 (50%)  1 (12.25%)  3 (37.5%) 8 (100%)  
 













Table XII: Correlation between foetal weight and 
placental weight among cases 
 
  65 
Placental weight (grams)  Foetal 
weight (kg) < 400 400 - 500  > 500 
Total  
< 1.5 9 (75%) 3 (25%)  0 (0.0 %)  12 (100%)  
1.5 - 2.5  4 (12.12%)  26 (78.79%)  3 (9.09%) 33 (100%)  
> 2.5 0 (0.0%)  15 (42.86%)  20 (57.14%) 35 (100%)  
 













Table XIII: Correlation between foetal outcome and 
placental weight among cases 
 
  66 
Placental weight (grams)  Foetal 
outcome < 400 400 - 500  > 500 
Total  
Alive  9 (12.5%) 40 (55.56%)  23 (31.94 %)  72 (100%)  
Stillbirth  4 (50%)  4 (50%)  0 (0.0%) 8 (100%)  
 













Table XIV: Correlation between placental weight and 
proteinuria among cases 
 
  67 
Proteinuria (in +) Placental 
weight (gm) Nill 1 - 2 3- 4 
Total  
< 400 0 (0.0%) 7 (54%)  6 (46 %)  13 (100%)  
400 - 500 8 (18%) 29 (66%)  7 (16 %)  44 (100%)  
>500  6 (26%)  16 (70%)  1 (4.0%) 23 (100%)  
 













Table XV: Correlation between placental weight and foetal 
weight ( >2.5 and ≤ 2.5 kg) among cases 
 
  68 
Placental weight (grams)  Foetal 
weight (Kg) < 400 400 - 500  > 500 
Total  
> 2.5 0 (0.0%) 15 (42.86%)  20 (57.14 %)  35 (100%)  
≤ 2.5 13 (28.89%)  29 (64.44%)  3 (6.67%) 45 (100%)  
 













Table XVI: Correlation between placental weight and need 
for neonatal resuscitation among the study group   
  69 




Yes  No  
Total  
< 400  9 (100%)  0 (0.0%) 9 (100%) 
400 - 500 10 (25%)  30 (75%) 40 (100%) 
> 500 0 (0.0%)  23 (100%)  23 (100%) 
 













Table XVII: Correlation between placental weight and 
Apgar score among cases 
  70 
 
Placental weight (grams)  Apgar score 
< 400 400 - 500  > 500 
Total  
≥ 7 0 (0.0%) 30 (65.6%)  23 (43.4 %)  53 (100%)  
< 7 13 (48.1%)  14 (51.9%)  0 (0.0%) 27 (100%)  
 













Table XVIII:  Correlation between foetal weight and 
placental weight in foetal gestational age > 34 weeks 
  71 
 among the cases   
Placental weight (grams)  Foetal weight 
(Kg) 400 - 500 > 500 
Total  
< 1.5  1 (100%)  0 (0.0%)  1 (100%)  
1.5 - 2.5 9 (90%)  1 (10%)  10 (100%)  
> 2.5 5 ( 33.3%)  10 (66.7%)  15 (100%)  
 
















































































































































































































The incidence of PIH increasing throughout the world, 
but with good antenatal care and good nursing facilities, the 
  83 
outcome was improved regarding foetal and maternal 
outcome.  
PIH is a disease of primigravidae irrespective of their 
age, it was found to be in maternal age <20 years just 1.25% 
and was more common in the age between 20 - 29 years in a 
percentage of 67.5% in this study. This may be due to the 
increase in the marriage age in our community.(2) Although 
32% of the cases were living in rural areas, just 11.25% of 
cases had no antenatal care, while 6.25% of the control group 
had no antenatal care, this was reflected in the good foetal 
and maternal outcome and also this may be due to the fact 
that most of the study group were belonging to the Police 
Force who were treated in Ribat Hospital freely.  
Education plays an important role in utilizing the 
available health services, so educated women can get the best 
from these services, in this study about 30% were illiterate 
and about 70% of cases had some sort of education, this also 
reflected in good antenatal care and good foetal and maternal 
outcome. Individuals with good socioeconomic status had the 
ability to have easy access to best health services, but in this 
study, 76% of the cases and 66% of the control group were 
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belonging to low socioeconomic status, and this did not affect 
their antenatal care and so the good outcome because of the 
free medical services they had.  
About 23% of the cases gave past history of PIH in 
their previous pregnancies and non of the control group did 
so. These patients need thorough early follow-up during their 
future pregnancies.  
Sixteen percent of cases in this study gave a history of 
IUGR in their previous pregnancies and 23% had a past 
history of PIH, this showed the strong relationship between 
PIH and IUGR.  
Regarding mode of delivery, 75% of the cases ended in 
C/S, while 96% of the control group ended with normal 
vaginal delivery. This might be because, the time factor is so 
crucial in dealing with severe pre-eclampsia, so C/S is the 
faster way to terminate pregnancy.(34)  
Patients with PIH gave birth to babies lighter than 
those with normal blood pressure, 75% of the control group 
had babies with birth weight >2.5 kg and no babies <1.5 kg, 
while in the cases 15% of the babies had birth weight  <1.5kg 
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and 43% had birth weight >2.5kg, this reflected the great 
effect of the PIH upon the foetal weight.   
2.5% of the control babies had resuscitation and not 
admitted to the NICU, while about 23% of the cases babies 
had resuscitation and most of them admitted to the NICU, 
this was most likely due to iatrogenic prematurity.  
About 16% of the cases had placental weight <400 gm 
and 28% had placental weight >500 gm, while no control 
group had placental weight <400 gm and more than 50% had 
placental weight >500 gm. This will reflect the effect of PIH on 
placental weight.  
All control group gave birth to alive babies, while 10% 
of the cases group gave birth to stillbirths. This will reflect the 
bad effect of the PIH on the foetal outcome.  
Correlation between foetal outcome and gestational 
age showed that with gestational age <28 weeks had 50% of 
the stillbirths among the study group. This showed the bad 
effect of PIH in neonatal outcome either by causing 
intrauterine foetal death or early neonatal death due to 
prematurity resulting from iatrogenic termination of 
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pregnancy to decrease maternal mortality and morbidity due 
to the complication of severe preeclampsia.  
Correlation between diastolic blood pressure and 
proteinuria showed that 37% of cases with diastolic blood 
pressure <100 mm Hg had no proteinuria and all patients 
with diastolic blood pressure more than 110 mmHg had 
proteinuria. This reflects the effect of severe pre-eclampsia on 
the kidneys.  
Correlation between placental weight and foetal 
outcome showed that no foetal losses with placental weight 
>500gm and 50% of babies with placenta <400gm were 
stillbirths.  
Correlation between foetal weight and placental weight 
showed that 57% of babies weighing >2.5 kg, if the placental 
weight more than 500 gm and all babies <2.5kg, when the 
placental weight was <400 gm. This reflect the effect of poor 
blood supply on the foetal weight (poor placental perfusion 
caused by PIH).  
Correlation between placental weight and need for 
neonatal resuscitation showed that all babies with placental 
weight <400 gm had resuscitation and no baby with placental 
  87 
weight >500 gm had resuscitation, this reflect the need of 
dealing with cases of PIH in hospitals with well equipped 
neonatal care services.  
Correlation between placental weight and Apgar score 
at 5 minutes showed that no baby with placental weight <400 
gm had Apgar score ≥7, while 48% of babies with placental 
weight <400 gm and no baby with placental weight >500 gm 
had Apgar score <7, this reflect the good effect of good 
placental weight on the Apgar score. 
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• The incidence of PIH was high in low 
socioeconomic group and in those with low parities and 
primigravidae, also in patients with history of PIH.  
• The significant problems were residence, past 
history of PIH, past history of IUGR, mode of delivery, 
foetal weight, need for neonatal intensive care unit 
admission, need for neonatal resuscitation, Apgar score, 
placental weight and foetal outcome.  
• The major risk factors contributed to PIH patients 
were age, parity and past history of PIH,  
• The high incidence of C/S was to lower maternal 
and foetal mortality and morbidity.  
• PIH adversely affected placental weight, this lead 
to low birth weight and poor foetal outcome.  
• This study showed that most problems of PIH can 
be minimized by improving the socioeconomic status of 
the patients, the availability and accessibility to health 
services and by improving the educational level of the 
population. Also by considering PIH patients as 
extremely high risk patients.   
RECOMMENDATIONS  
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• Management protocols for PIH, preeclampsia and 
eclampsia will improve the maternal and foetal outcome 
by making treatment and follow up easy for medical 
service providers in hospitals and disciplinary units.  
• Continuous monitoring for patients with severe 
preeclampsia and eclampsia can lower the maternal 
morbidity and mortality.  
• Blood pressure should be carefully and slowly 
lowered to avoid jeopardy of placental and cerebral 
perfusion.  
• Severe life threatening hypertension must be 
effectively dealt with, even by termination of pregnancy 
at any gestational age.  
• Specialization of intensive care should be 
encouraged and all cases of severe preeclampsia and 
eclampsia should be treated in Intensive Care Unit.  
• Patients with PIH should be educated regarding 
the implication of the disease on their life and should 
know the signs and symptoms of severe preeclampsia 
and what to do if they develop.  
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• Labour room staff should be familiar in dealing 
with emergency like eclampsia:  
- ABC, aborting fits and preventing other 
fits (the drug of choice is magnesium sulphate).  
- The foetus should be delivered after 
stabilization of the patient and this took up to 6 to 
12 hours from admission. C/S is often indicated.  
-  General anaesthesia administered by 
skilled anaesthetist is recommended. When the 
facilities are not available, epidural anaesthesia 
would be adequate providing that hypotensive 
episodes to be prevented by sufficient intravenous 
pre-loading and coagulopathy is excluded by 
estimation of clotting time, fibrinogen level and 
platelet counts.  
• Multidisciplinary approach is highly 
recommended in dealing with eclampsia and pre-
eclampsia, i.e. senior obstetrician, neonatologist, 
anesthetist, haematologist, intensive care specialist and 
trained intensive care unit nurse.  
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• While prevention of preeclampsia and eclampsia 
need understanding of its aetiology, which not explored 
yet, so improvement in ANC to allow active management 
of the disease will improve both foetal and maternal 
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 ﻡﻴﺤﺭﻟﺍ  ﻥﻤﺤﺭﻟﺍ  ﷲﺍ  ﻡﺴﺒ  
University of Khartoum 
Faculty of Medicine 
Postgraduate Medical Studies Board  
 
Placental weight in PIH patients  
 
Serial No.:......................      Name:.....................…………………..................     
Address:........…………………………………………...............….................. 
…………………………………………………………………………  
1- Age (in years):              i- < 20                  ii- 20-29                   iii- ≥ 30     
2- Residence:                     i- Rural                ii- Urban    
3- Education:         i- Illiterate         ii- Primary/secondary             iii- University  
4- Socioeconomic:  i- Low               ii- Moderate            iii- High 
5- Antenatal care:  i- Regular          ii- Infrequent           iii- No antenatal care        
6- Parity:                 i- Nulliparous            ii-  1- 4           iii- > 4           
7- Past history:                      
a. Past history of PIH:                i- Yes                 ii- No   
b. Past history of IUGR:            i- Yes                 ii- No   
c. Past history of syphilis:           i- Yes                 ii- No   
8- Current obstetrical history:                      
a. Gestational age at delivery:  ……………………….. weeks                 
b. Diabetes mellitus:                    i- Yes                 ii- No   
c. Antihypertensive drugs during pregnancy:   i- Yes                 ii- No   
9- O/E:                
a. Oligohydramnios in the 3rd trimester:   i- Yes                 ii- No   
b. Diastolic blood  pressure:  ………………………………………………….  
c. Proteinuria:   i- No +                  ii-  1- 2+                   iii- 3-4+ 
10. Past medical history:                      
a. Chronic hypertension:             i- Yes                 ii- No   
b. Antiphospholipid syndrome:   i- Yes                 ii- No   
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11. Mode of delivery:          i- NVD           ii- induction                  iii- C/S  
12. Foetal outcome:             i- Alive           ii- Stillbirth              
13. Foetal weight:  ……………………………….. kg.  
14. Need  for neonatal resuscitation:          i- Yes               ii- No 
15. Apgar score at 5 minutes:                      i- ≥ 7                ii- < 7                                     
16. Admission to the Neonatal Intensive Care Unit:  i- Yes               ii- No 
17. Any problem during placental delivery:     i- Yes               ii- No 
18. Placental weight: ……………………………………………………. 
                     
       
                    
 
  
 
 
 
 
 
